Systematic interrogation of mutation groupings reveals divergent downstream expression programs within key cancer genes

• Main Authors: Michal R. Grzadkowski, Hannah D. Holly, Julia Somers, Emek Demir
• Format: Article
• Language: English
• Published: BMC 2021-05-01
• Series: BMC Bioinformatics
• Subjects: Cancer; Transcriptomics; Machine learning; Genomic variants; Drug response
• Online Access: https://doi.org/10.1186/s12859-021-04147-y
• ISSN: 1471-2105

Abstract Background Genes implicated in tumorigenesis often exhibit diverse sets of genomic variants in the tumor cohorts within which they are frequently mutated. For many genes, neither the transcriptomic effects of these variants nor their relationship to one another in cancer processes have been well-characterized. We sought to identify the downstream expression effects of these mutations and to determine whether this heterogeneity at the genomic level is reflected in a corresponding heterogeneity at the transcriptomic level. Results By applying a novel hierarchical framework for organizing the mutations present in a cohort along with machine learning pipelines trained on samples’ expression profiles we systematically interrogated the signatures associated with combinations of mutations recurrent in cancer. This allowed us to catalogue the mutations with discernible downstream expression effects across a number of tumor cohorts as well as to uncover and characterize over a hundred cases where subsets of a gene’s mutations are clearly divergent in their function from the remaining mutations of the gene. These findings successfully replicated across a number of disease contexts and were found to have clear implications for the delineation of cancer processes and for clinical decisions. Conclusions The results of cataloguing the downstream effects of mutation subgroupings across cancer cohorts underline the importance of incorporating the diversity present within oncogenes in models designed to capture the downstream effects of their mutations.